Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Lifeward (Nasdaq: LFWD) has announced the postponement of its Extraordinary General Meeting of Shareholders from December 30, 2024, to January 13, 2025, at 10:00 a.m. EST. The meeting will be held at the Company’s offices in Marlborough, MA. The postponement is due to an anticipated lack of quorum and to allow additional time for proxy solicitation.
The record date remains November 20, 2024. The Board unanimously recommends voting FOR the proposals outlined in the proxy statement. Previously cast votes remain valid unless shareholders choose to change them. The company plans to hold an Investor Day following the meeting, with the date to be announced.
Lifeward (Nasdaq: LFWD) ha annunciato il rinvio della sua Assemblea Generale Straordinaria degli Azionisti dal 30 dicembre 2024 al 13 gennaio 2025, alle 10:00 EST. L’incontro si terrà presso gli uffici della Società a Marlborough, MA. Il rinvio è dovuto a un’anticipata mancanza di quorum e per consentire ulteriore tempo per la sollecitazione delle deleghe.
La data di registrazione rimane il 20 novembre 2024. Il Consiglio raccomanda unanimemente di votare a FAVORE delle proposte delineate nel documento di delega. I voti già espressi rimangono validi a meno che gli azionisti non decidano di modificarli. La società prevede di tenere un Investor Day successivamente all’assemblea, con la data che sarà annunciata.
Lifeward (Nasdaq: LFWD) ha anunciado el aplazamiento de su Junta General Extraordinaria de Accionistas del 30 de diciembre de 2024 al 13 de enero de 2025, a las 10:00 a.m. EST. La reunión se llevará a cabo en las oficinas de la Compañía en Marlborough, MA. El aplazamiento se debe a una anticipada falta de quórum y para permitir tiempo adicional para la solicitud de poderes.
La fecha de registro sigue siendo el 20 de noviembre de 2024. La Junta recomienda unánimemente votar A FAVOR de las propuestas descritas en el documento de poder. Los votos emitidos anteriormente siguen siendo válidos a menos que los accionistas elijan cambiarlos. La compañía planea llevar a cabo un Día del Inversor después de la reunión, con la fecha por anunciar.
Lifeward (Nasdaq: LFWD)는 주주 특별 총회가 2024년 12월 30일에서 2025년 1월 13일 오전 10시 EST로 연기된다고 발표했습니다. 회의는 매사추세츠주 말보로에 위치한 회사 사무실에서 개최됩니다. 연기의 이유는 예상되는 재적 인원의 부족과 대리 투표 요청을 위한 추가 시간을 허용하기 위함입니다.
기록일자는 2024년 11월 20일로 유지됩니다. 이사회는 위임장에 명시된 제안에 대해 찬성 투표를 할 것을 전적으로 권장합니다. 이전에 행사된 투표는 주주가 변경하기로 선택하지 않는 한 유효합니다. 회사는 회의 후 투자자 데이 개최를 계획하고 있으며, 날짜는 추후 발표될 예정입니다.
Lifeward (Nasdaq: LFWD) a annoncé le report de son Assemblée Générale Extraordinaire des Actionnaires du 30 décembre 2024 au 13 janvier 2025, à 10h00 EST. La réunion se tiendra dans les bureaux de la Société à Marlborough, MA. Le report est dû à un manque de quorum anticipé et pour permettre un temps supplémentaire pour la solicitude de procurations.
La date d’enregistrement reste le 20 novembre 2024. Le Conseil recommande à l’unanimité de voter POUR les propositions énoncées dans le document de procuration. Les votes précédemment exprimés restent valides, à moins que les actionnaires ne choisissent de les modifier. La société prévoit de tenir une Journée des Investisseurs après la réunion, la date sera annoncée ultérieurement.
Lifeward (Nasdaq: LFWD) hat die Verschiebung seiner Außerordentlichen Hauptversammlung der Aktionäre vom 30. Dezember 2024 auf den 13. Januar 2025 um 10:00 Uhr EST bekannt gegeben. Die Versammlung findet in den Büroräumen des Unternehmens in Marlborough, MA statt. Die Verschiebung erfolgt aufgrund eines voraussichtlichen Mangels an Quorum und um zusätzliche Zeit für die Ausschreibung von Vollmachten zu ermöglichen.
Der Stichtag bleibt der 20. November 2024. Der Vorstand empfiehlt einstimmig, den im Vollmachtsformular skizzierten Vorschlägen zuzustimmen. Bereits abgegebene Stimmen bleiben gültig, es sei denn, die Aktionäre entscheiden sich, diese zu ändern. Das Unternehmen plant, nach der Versammlung einen Aktionärstag abzuhalten, dessen Datum noch bekannt gegeben wird.
Negative
- Meeting postponed due to lack of quorum indicating potential shareholder engagement issues
- Need for extended proxy solicitation period suggests difficulty in achieving required shareholder participation
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, today announced that the Company’s Extraordinary General Meeting of Shareholders (the “Meeting), which was originally scheduled to be held on Monday, December 30, 2024, has been postponed. The Meeting is now scheduled to be held at 10:00 a.m. (Eastern Standard Time) on Monday, January 13, 2025 at the Company’s offices at 200 Donald Lynch Blvd., Marlborough, MA 01752, U.S.A. The record date for the Meeting, November 20, 2024, is unchanged and applies to the postponed Meeting.
The Meeting has been postponed due to an anticipated lack of quorum, and to provide further time to solicit proxies from the Company’s shareholders. Lifeward’s Board of Directors unanimously recommends that you vote FOR the proposals identified in the Company’s proxy statement for the Meeting. Shareholders who have already cast their votes do not need to take any action, unless they wish to change or revoke their prior proxy or voting instructions, and their votes will be counted at the postponed Meeting. For shareholders who have not yet cast their votes, we urge them to vote their shares now, so they can be tabulated prior to the postponed Meeting.
The Company plans to hold an Investor Day soon after the Meeting, with the exact date to be confirmed.
Important Additional Information
The Company has filed a Definitive Proxy Statement with the Securities and Exchange Commission (the “SEC”) on November 25, 2024 (the “Proxy Statement”), which should be read in conjunction with this notice. To the extent information in this notice updates or conflicts with information contained in the Proxy Statement, the information in this notice is the more current information. SHAREHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY LIFEWARD AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT ANY SOLICITATION. Shareholders may obtain a free copy of the proxy statement and the other relevant materials, and any other documents filed by Lifeward with the SEC, at the SEC’s web site at https://www.sec.gov or on the “SEC Filings” section of Lifeward’s website at https://golifeward.com/.
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity System, the MyoCycle FES System, and the ReStore Exo-Suit.
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward product portfolio, please visit GoLifeward.com.
Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
Forward-Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may be identified by words like “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “should,” “would,” “seek” and similar terms or phrases. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from the Company’s current expectations. These and other risks are more fully discussed in the Company’s periodic filings with the SEC, including the risk factors described under the heading “Risk Factors” in the Company’s annual report on Form 10-K and 10-K/A for the year ended December 31, 2023 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
Lifeward Media Relations:
Kathleen O’Donnell
VP Marketing & New Business Development
Lifeward
E: media@golifeward.com
Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
Lifeward
E: ir@golifeward.com
FAQ
When is Lifeward’s (LFWD) rescheduled Extraordinary General Meeting?
Lifeward’s Extraordinary General Meeting has been rescheduled to Monday, January 13, 2025, at 10:00 a.m. EST at the Company’s offices in Marlborough, MA.
Why did Lifeward (LFWD) postpone its December 2024 shareholders meeting?
Lifeward postponed the meeting due to an anticipated lack of quorum and to provide additional time to solicit proxies from shareholders.
Do LFWD shareholders need to revote after the meeting postponement?
No, shareholders who have already cast their votes do not need to take any action unless they wish to change or revoke their prior proxy or voting instructions.
What is the record date for Lifeward’s (LFWD) postponed Extraordinary General Meeting?
The record date remains November 20, 2024, and applies to the postponed Meeting.
What is the Board’s recommendation for LFWD’s shareholder proposals?
Lifeward’s Board of Directors unanimously recommends that shareholders vote FOR the proposals identified in the Company’s proxy statement.
